SIGMA-VB: Validity and reliability of the Brazilian Portuguese version of the Montgomery-Asberg Depression Rating Scale using the Structured Interview Guide for the MADRS

Imagem de Miniatura
Arquivos
art_FERNANDES_SIGMAVB_Validity_and_reliability_of_the_Brazilian_Portuguese_2019.PDF (197.28 KB)
Citações na Scopus
7
Tipo de produção
article
Data de publicação
2019
DOI
SciELO
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ASSOC BRASILEIRA PSIQUIATRIA
Autores
CAMPOS, Rodolfo N.
BARROS, Vivian B.
Citação
REVISTA BRASILEIRA DE PSIQUIATRIA, v.41, n.4, p.297-302, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective: The Montgomery-Asberg Depression Rating Scale (MADRS) is widely used to assess depression severity. The Structured Interview Guide for the MADRS (SIGMA) was created to standardize MADRS assessment. The objective of this study was to translate and validate the original SIGMA into a Brazilian Portuguese version (SIGMA-VB). Methods: We translated and cross-culturally validated the original SIGMA into the SIGMA-VB, and assessed its psychometric properties using data from 93 adult outpatients enrolled in the Integral Assessment in Unipolar Depression (AIUNI) trial. Participants were assessed by two raters on five visits over 8 weeks. We calculated multiple interrater reliability indexes for the SIGMA-VB and used the Hamilton Depression Hating Scale (HAM-D) for validation purposes. Results: According to the SIGMA-VB, participants had moderate depression at baseline followed by mild depression at 8 weeks. We found over 90% of correlation between scores attributed by different raters using the SIGMA-VB. Correlations between the SIGMA-VB and the HAM-D were above 66%. Conclusion: Our findings confirm that the SIGMA-VB is a valid and reliable instrument to assess depression severity in clinical research and practice. Its interrater reliability was similar to that of a previously published Japanese version of the SIGMA.
Palavras-chave
Psychiatric status rating scales, depression, depressive disorder, validation studies as topic
URI
https://observatorio.fm.usp.br/handle/OPI/33647
Referências
  1. Ahmadpanah M, 2016, NEUROPSYCH DIS TREAT, V12, P603, DOI 10.2147/NDT.S103869
  2. Bagby RM, 2004, AM J PSYCHIAT, V161, P2163, DOI 10.1176/appi.ajp.161.12.2163
  3. Blacker D., 2005, KAPLAN SADOCKS COMPR, P755
  4. Bondolfi G, 2010, J AFFECT DISORDERS, V121, P268, DOI [10.1016/j.jad.12009.06.037, 10.1016/j.jad.2009.06.037]
  5. Cano Juan Fernando, 2016, rev.colomb.psiquiatr., V45, P146, DOI [10.1016/j.rcp.2015.08.0060034-7450, 10.1016/j.rcp.2015.08.006]
  6. Carmody TJ, 2006, EUR NEUROPSYCHOPHARM, V16, P601, DOI 10.1016/j.euroneuro.2006.04.008
  7. Carneiro AM, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0235-3
  8. DAVIDSON J, 1986, ACTA PSYCHIAT SCAND, V73, P544, DOI 10.1111/j.1600-0447.1986.tb02723.x
  9. DRATCU L, 1987, BRIT J PSYCHIAT, V150, P797, DOI 10.1192/bjp.150.6.797
  10. First M. B., 2002, STRUCTURED CLIN INTE
  11. HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56
  12. Huijbrechts IPAM, 1999, ACTA NEUROPSYCHIATR, V11, P34, DOI 10.1017/S0924270800036358
  13. KEARNS NP, 1982, BRIT J PSYCHIAT, V141, P45, DOI 10.1192/bjp.141.1.45
  14. Khan A, 2004, INT CLIN PSYCHOPHARM, V19, P157, DOI 10.1097/01.yic.0000125755.91123.3f
  15. Kriston L, 2011, J AFFECT DISORDERS, V128, P175, DOI 10.1016/j.jad.2010.07.011
  16. Leucht S, 2017, J AFFECT DISORDERS, V210, P287, DOI 10.1016/j.jad.2016.12.041
  17. Lingjaerde O, 1987, Acta Psychiatr Scand Suppl, V334, P1
  18. Liu J, 2014, J AFFECT DISORDERS, V152, P530, DOI 10.1016/j.jad.2013.09.023
  19. Lobo A, 2002, MED CLIN-BARCELONA, V118, P493, DOI 10.1016/S0025-7753(02)72429-9
  20. MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382
  21. Quilty LC, 2013, INT J METH PSYCH RES, V22, P175, DOI 10.1002/mpr.1388
  22. R Core Team, 2013, R LANG ENV STAT COMP
  23. Rohan KJ, 2016, J AFFECT DISORDERS, V200, P111, DOI 10.1016/j.jad.2016.01.051
  24. Santen G, 2009, J PSYCHIATR RES, V43, P1049, DOI 10.1016/j.jpsychires.2009.02.001
  25. Schmidtke A, 1988, Schweiz Arch Neurol Psychiatr (1985), V139, P51
  26. SKRE I, 1991, ACTA PSYCHIAT SCAND, V84, P167, DOI 10.1111/j.1600-0447.1991.tb03123.x
  27. Soron TR, 2017, ASIAN J PSYCHIATR, V28, P41, DOI 10.1016/j.ajp.2017.03.019
  28. Takahashi N, 2004, HUM PSYCHOPHARM CLIN, V19, P187, DOI 10.1002/hup.576
  29. von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013
  30. Williams JBW, 2008, BRIT J PSYCHIAT, V192, P52, DOI 10.1192/bjp.bp.106.032532
  31. World Health Organization, 2009, PROC TRANSL AD INSTR
  32. Yee A, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0587-6
  33. Zimmerman M, 2005, J CLIN PSYCHOPHARM, V25, P105, DOI 10.1097/01.jcp.0000155824.59585.46

Coleções
Artigos e Materiais de Revistas Científicas - HC/IPq
Artigos e Materiais de Revistas Científicas - LIM/23